Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Better vision for aging eyes: new lenses tackle two problems at once

NCT ID NCT06461455

Symptom relief Sponsor: Alcon Research Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested new multifocal contact lenses designed for people with both presbyopia (age-related blurry near vision) and astigmatism (blurry vision due to an irregularly shaped cornea). 95 habitual contact lens wearers wore the lenses for 30 days, and researchers measured how clearly they could see at a distance. The goal was to see if the new lenses perform well in everyday use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Lehfilcon A multifocal for astigmatism contact lenses
What this could lead to
If successful, this could offer a new comfortable contact lens option for people who need both multifocal and astigmatism correction.
What could go wrong
This is a small completed study comparing two lens types, so results may not apply to all users. Individual comfort and vision can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

95 people

The number who actually took part.

Started

Jul 2024

Finished

Dec 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Key Inclusion Criteria: * Habitual wearer of biweekly/monthly replacement soft multifocal or multifocal toric contact lenses in both eyes for a minimum of 5 days per week and 8 hours per day during the past 3 months; * Manifest cylinder equal to or greater than 0.75 diopter (D) in each eye at Screening; * Willing to not use readers while wearing study contact lenses for duration of the study; * Other protocol-defined inclusion criteria may apply. Key Exclusion Criteria: * Use of topical ocular medications and artificial tear or rewetting drops that would require instillation during contact lens wear; * Wears habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment; * Monovision contact lens wearers and wearers of contact lens in one eye only; * Other protocol-defined exclusion criteria may apply.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Astigmatism are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

astigmatism hyperopia myopia presbyopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Astigmatism Presbyopia

Contacts and locations

Locations

  • Dawn M. Rakich, OD

    San Antonio, Texas, 78213, United States

  • Dr.Elsa Pao, O.D

    Oakland, California, 94607, United States

  • Drs. Giedd, P.A.

    Maitland, Florida, 32751, United States

  • Insight Research Clinic LLC

    Powell, Ohio, 43065, United States

  • Kannarr Eye Care LLC

    Pittsburg, Kansas, 66762, United States

  • Oculus Research, Inc.

    Garner, North Carolina, 27529, United States

  • Optometry Group, PLLC

    Memphis, Tennessee, 38111, United States

  • Pacific Rims Optometry

    San Francisco, California, 94127, United States

  • ProCare Vision Centers, Inc.

    Granville, Ohio, 43023, United States

  • Vision Health Institute

    Orlando, Florida, 32803, United States

  • Wesley Optometric Consulting

    Medina, Minnesota, 55340, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.